BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18838435)

  • 1. Specific protein delivery to target cells by antibody-displaying bionanocapsules.
    Kurata N; Shishido T; Muraoka M; Tanaka T; Ogino C; Fukuda H; Kondo A
    J Biochem; 2008 Dec; 144(6):701-7. PubMed ID: 18838435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of arginine-rich peptide displaying bionanocapsules.
    Shishido T; Yonezawa D; Iwata K; Tanaka T; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1473-6. PubMed ID: 19200722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotinylated bionanocapsules for displaying diverse ligands toward cell-specific delivery.
    Shishido T; Azumi Y; Nakanishi T; Umetsu M; Tanaka T; Ogino C; Fukuda H; Kondo A
    J Biochem; 2009 Dec; 146(6):867-74. PubMed ID: 19710034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
    Shishido T; Mieda H; Hwang SY; Nishimura Y; Tanaka T; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5726-31. PubMed ID: 20801029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specific delivery of proteins to human liver cells by engineered bio-nanocapsules.
    Yu D; Amano C; Fukuda T; Yamada T; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada H; Tada H; Seno M
    FEBS J; 2005 Jul; 272(14):3651-60. PubMed ID: 16008564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory production system of bionanocapsules using a stably transfected insect cell line.
    Shishido T; Muraoka M; Ueda M; Seno M; Tanizawa K; Kuroda S; Fukuda H; Kondo A
    Appl Microbiol Biotechnol; 2006 Dec; 73(3):505-11. PubMed ID: 16847600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials.
    Jung J; Matsuzaki T; Tatematsu K; Okajima T; Tanizawa K; Kuroda S
    J Control Release; 2008 Mar; 126(3):255-64. PubMed ID: 18207275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroporation and use of hepatitis B virus envelope L proteins as bionanocapsules.
    Yamada T; Jung J; Seno M; Kondo A; Ueda M; Tanizawa K; Kuroda S
    Cold Spring Harb Protoc; 2012 Jun; 2012(6):702-5. PubMed ID: 22661433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.
    Kasuya T; Jung J; Kinoshita R; Goh Y; Matsuzaki T; Iijima M; Yoshimoto N; Tanizawa K; Kuroda S
    Methods Enzymol; 2009; 464():147-66. PubMed ID: 19903554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient delivery of antibody into living cells using a novel HVJ envelope vector system.
    Kondo Y; Fushikida K; Fujieda T; Sakai K; Miyata K; Kato F; Kato M
    J Immunol Methods; 2008 Mar; 332(1-2):10-7. PubMed ID: 18221753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery.
    Mei H; Shi W; Pang Z; Wang H; Lu W; Jiang X; Deng J; Guo T; Hu Y
    Biomaterials; 2010 Jul; 31(21):5619-26. PubMed ID: 20413154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-nanocapsules displaying various immunoglobulins as an active targeting-based drug delivery system.
    Tatematsu K; Iijima M; Yoshimoto N; Nakai T; Okajima T; Kuroda S
    Acta Biomater; 2016 Apr; 35():238-47. PubMed ID: 26876802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bionanocapsule-based enzyme-antibody conjugates for enzyme-linked immunosorbent assay.
    Iijima M; Matsuzaki T; Kadoya H; Hatahira S; Hiramatsu S; Jung G; Tanizawa K; Kuroda S
    Anal Biochem; 2010 Jan; 396(2):257-61. PubMed ID: 19819216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous intracellular delivery of targeting antibodies and functional nanoparticles with engineered protein G system.
    Lim YT; Cho MY; Lee JM; Chung SJ; Chung BH
    Biomaterials; 2009 Feb; 30(6):1197-204. PubMed ID: 19056121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
    J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered bio-nanocapsules, the selective vector for drug delivery system.
    Yu D; Fukuda T; Tuoya ; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada T; Tada H; Seno M
    IUBMB Life; 2006 Jan; 58(1):1-6. PubMed ID: 16596748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells.
    Matsuo H; Yoshimoto N; Iijima M; Niimi T; Jung J; Jeong SY; Choi EK; Sewaki T; Arakawa T; Kuroda S
    Int J Nanomedicine; 2012; 7():3341-50. PubMed ID: 22848163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
    Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
    Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of bionanocapsules targeting brain tumors.
    Tsutsui Y; Tomizawa K; Nagita M; Michiue H; Nishiki T; Ohmori I; Seno M; Matsui H
    J Control Release; 2007 Sep; 122(2):159-64. PubMed ID: 17692421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperbranched polysiloxysilane nanoparticles: surface charge control of nonviral gene delivery vectors and nanoprobes.
    Kim WJ; Bonoiu AC; Hayakawa T; Xia C; Kakimoto MA; Pudavar HE; Lee KS; Prasad PN
    Int J Pharm; 2009 Jul; 376(1-2):141-52. PubMed ID: 19409467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.